Status:
ACTIVE_NOT_RECRUITING
Endovascular Treatment of Cerebrovascular Diseases Guided by Optical Coherence Tomography (OCT) Technology（CVD-OCT）
Lead Sponsor:
First Affiliated Hospital of Wannan Medical College
Conditions:
Carotid Stenosis
Optical Coherence Tomography (OCT)
Eligibility:
All Genders
Brief Summary
OCT techniques have been used in the assessment of both intracranial and extracranial lesions.(1) Preprocedural evaluation: The morphologic characteristics of carotid atherosclerotic plaques can be ev...
Detailed Description
Stroke is a kind of acute focal damage to the central nervous system caused by vascular lesions, resulting in neurological function defects. With the characteristics of high morbidity, high disability...
Eligibility Criteria
Inclusion
- Presence of cerebrovascular disease (including asymptomatic patients);
- Cerebral angiography or intervention with OCT is required in the course of clinical diagnosis and treatment;
- Informed consent signed by the patient or the patient's legally authorized representative.
Exclusion
- Patients with contrast allergy or intolerance to iodine contrast;
- Patients with tortuous blood vessels who are unable to complete OCT.
Key Trial Info
Start Date :
November 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06986330
Start Date
November 30 2023
End Date
December 31 2025
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China